中性粒细胞弹性酶促进低分子量环林E1的形成,以加速骨髓瘤的扩散
Jiuhui Xu1,2, Qianyu Shi1,2, Fanwei Zeng1,2
1Department of Musculoskeletal Tumor, Peking University People's Hospital, Beijing, China.
Frontiers in immunology
|September 17, 2025
概括
一种低分子量环林E1异型 (LMW-环林E1) 驱动骨髓瘤 (OS) 的进展. 与瘤相关的中性粒细胞释放弹性酶 (ELA2),产生LMW-环林E1,促进OS恶性瘤和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓瘤 (OS) 是一种具有高转移潜力的原发性骨癌.
- 已知Cyclin E1在OS中受到上调.
- 在OS中发现了一种新的细胞质,低分子量环林E1异型 (LMW-环林E1).
研究的目的:
- 调查LMW-cyclin E1在骨髓瘤中的作用.
- 为了阐明LMW-cyclin E1形成的机制.
- 探索针对中性粒细胞与骨肉瘤相互作用的治疗潜力.
主要方法:
- RNA测序和西班牙血迹分析环林E1表达.
- 免疫光和免疫组织化学用于验证.
- 中性粒细胞和OS细胞的体外共同培养,体内小鼠模型和患者组织分析.
主要成果:
- 来自瘤关联中性粒细胞的ELA2将全长环林E1分裂为LMW-环林E1,加速OS的扩散.
- 中性粒细胞透与OS肺转移相关.
- OS细胞诱导中性粒细胞外细胞陷的形成,放大ELA2的释放.
结论:
- LMW-cyclin E1是OS进展和转移的关键驱动因素.
- 中性粒细胞弹性酶 (ELA2) 对于LMW-环素E1生成至关重要.
- 针对中性粒细胞和骨髓瘤之间的交叉通话是一个有前途的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Positive Regulator Molecules
6.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K
Positive Regulator Molecules
134.4K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
134.4K
M-Cdk Drives Transition Into Mitosis
6.3K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K


